Campbell Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,573
Closed -$249K 69
2024
Q1
$249K Buy
+1,573
New +$250K 0.02% 77
2023
Q4
Sell
-1,460
Closed -$227K 67
2023
Q3
$227K Buy
1,460
+173
+13% +$28.5K 0.03% 65
2023
Q2
$213K Buy
+1,287
New +$208K 0.03% 71
2023
Q1
Sell
-1,152
Closed -$204K 76
2022
Q4
$204K Sell
1,152
-79
-6% -$13.6K 0.03% 72
2022
Q3
$201K Buy
1,231
+100
+9% +$16.9K 0.03% 73
2022
Q2
$201K Sell
1,131
-6
-0.5% -$1.07K 0.03% 55
2022
Q1
$202K Buy
+1,137
New +$193K 0.02% 76
2020
Q3
Sell
-791
Closed -$111K 216
2020
Q2
$111K Buy
+791
New +$115K 0.02% 89
2020
Q1
Sell
-1,858
Closed -$271K 57
2019
Q4
$271K Sell
1,858
-36
-2% -$4.88K 0.05% 53
2019
Q3
$245K Sell
1,894
-11
-0.6% -$1.45K 0.05% 55
2019
Q2
$265K Sell
1,905
-209
-10% -$28.9K 0.06% 49
2019
Q1
$296K Buy
+2,114
New +$283K 0.08% 37

Other funds holding JNJ

Campbell Wealth Management's JNJ Position: Q2 2024 in Review

Campbell Wealth Management sold out of Johnson & Johnson (JNJ) in Q2 2024, closing a stake of 1,573 shares — an estimated $249K sold.

Campbell Wealth Management first reported a position in JNJ in Q1 2019 and held it in 12 quarters. The position peaked at $296K in Q1 2019. 3,801 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.

  • Campbell Wealth Management reported no remaining Johnson & Johnson position as of Q2 2024 after selling out during the quarter.
  • Campbell Wealth Management sold 1,573 Johnson & Johnson shares in Q2 2024, an estimated $249K.
  • Campbell Wealth Management first reported a position in Johnson & Johnson in Q1 2019 and held it in 12 quarters.
  • Campbell Wealth Management's Johnson & Johnson position peaked at $296K in Q1 2019.
  • 3,801 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.

Based on Campbell Wealth Management's 13F filing for Q2 2024, filed 7 Aug 2024.